A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?
Open Access
- 30 January 2018
- journal article
- review article
- Published by AOSIS in African Journal of Primary Health Care & Family Medicine
- Vol. 10 (1) , e1-e5
Abstract
Background: The World Health Organization aims to reduce tuberculosis (TB) mortality rate from 15% in 2015 to 6.5% by 2025.Aim: This study determined the profile of TB and human immunodeficiency virus (HIV) co-infected patients who died in Mahalapye District, Botswana, while on anti-TB medication and the factors that contributed to such outcome.Setting: The study was conducted in the Mahalapye Health District in Botswana.Methods: This was a cross-sectional study that reviewed patient records from the Mahalapye District Health Management Team Electronic Tuberculosis Register from January 2013 to December 2015.Results: The majority of the TB and HIV co-infected patients were on antiretroviral therapy (ART) (486 [81.63%]) or were initiated cotrimoxazole preventive therapy (CPT) (518 [87.2%]) while taking anti-TB treatment. Seventy-three (13.6%) TB and HIV co-infected patients died before completing anti-TB treatment. Three-quarters (54 [74.4%]) of patients who died before completing anti-TB treatment were on ART, among them two patients who were on ART at least 3 months prior to commencing anti-TB. Also, the majority (64 [87.7%]) of TB and HIV co-infected patients were commenced on CPT prior to death. There was a bimodal density curve of death occurrence in those who did not commence ART and in those who did not commence CPT.Conclusion: This study established that TB and HIV co-infected patients had a TB mortality of 13.6%. A high mortality rate was observed during the first 3 months in those who did not take ART and during the second and the fifth month in those who did not commence CPT. Further study is needed to clarify this matter.Keywords
This publication has 11 references indexed in Scilit:
- Risk factors for mortality in TB patients: a 10-year electronic record review in a South African provinceBMC Public Health, 2017
- Independent predictors of tuberculosis mortality in a high HIV prevalence setting: a retrospective cohort studyAIDS Research and Therapy, 2015
- Mortality associated with tuberculosis/HIV co-infection among patients on TB treatment in the Limpopo province, South Africa.African Health Sciences, 2015
- Risk factors of treatment default and death among tuberculosis patients in a resource-limited settingAsian Pacific Journal of Tropical Medicine, 2014
- Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed hiv-infected adults: a prospective, clinic-based studyBMC Infectious Diseases, 2014
- Evaluation of the GeneXpert MTB/RIF Assay for Rapid Diagnosis of Tuberculosis and Detection of Rifampin Resistance in Pulmonary and Extrapulmonary SpecimensJournal of Clinical Microbiology, 2011
- Incidence and Predictors of Mortality and the Effect of Tuberculosis Immune Reconstitution Inflammatory Syndrome in a Cohort of TB/HIV Patients Commencing Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- A systematic review of risk factors for death in adults during and after tuberculosis treatment [Review article]The International Journal of Tuberculosis and Lung Disease, 2011
- Evaluation of outpatients with suspected pulmonary tuberculosis in a high HIV prevalence setting in Ethiopia: clinical, diagnostic and epidemiological characteristics.Scandinavian Journal of Infectious Diseases, 2002
- Pulmonary tuberculosis in Kweneng District, Botswana: delays in diagnosis in 212 smear-positive patients.1998